Insurance price of Evista to be lowed by 20%

Published: 2008-10-13 06:59:00

Updated: 2008-10-13 06:59:00

Lilly Korea has announced that its price of Evista (raloxifene hydrochloride) will be reduced by 20 percent from next month due to launching of generic versions.

The company is considering no compensation for small inventories available at pharmacy, despite complaints.

Evista is commonly re...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK